202 related articles for article (PubMed ID: 12860172)
1. Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma.
Rasi G; Pierimarchi P; Sinibaldi Vallebona P; Colella F; Garaci E
Int Immunopharmacol; 2003 Aug; 3(8):1169-76. PubMed ID: 12860172
[TBL] [Abstract][Full Text] [Related]
2. Does antiviral therapy prevent hepatocellular carcinoma?
Kwon H; Lok AS
Antivir Ther; 2011; 16(6):787-95. PubMed ID: 21900710
[TBL] [Abstract][Full Text] [Related]
3. [HCV-HBV infection].
Imamura M; Chayama K
Nihon Rinsho; 2006 Jul; 64(7):1310-3. PubMed ID: 16838649
[TBL] [Abstract][Full Text] [Related]
4. Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?
Lok AS
J Gastroenterol Hepatol; 2011 Feb; 26(2):221-7. PubMed ID: 21070361
[TBL] [Abstract][Full Text] [Related]
5. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
Schott E; Bergk A; Berg T
Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819
[TBL] [Abstract][Full Text] [Related]
6. Antiviral therapy using lamivudine and thymosin alpha1 for hepatocellular carcinoma coexisting with chronic hepatitis B infection.
Shuqun C; Mengchao W; Han C; Feng S; Jiahe Y; Wenming C; Zhengfeng Y; Yuxiang Z; Peijun W
Hepatogastroenterology; 2006; 53(68):249-52. PubMed ID: 16608033
[TBL] [Abstract][Full Text] [Related]
7. [Prophylaxis and treatment of chronic viral hepatitis as the prevention of hepatocellular carcinoma].
Pár A
Orv Hetil; 2009 Jan; 150(1):19-26. PubMed ID: 19091671
[TBL] [Abstract][Full Text] [Related]
8. Combination thymosin-alpha 1 and interferon-alpha 2b in the treatment of anti-HBe-positive chronic hepatitis B in Turkey.
Saruc M; Yuceyar H; Kucukmetin N; Demir MA; Kandiloglu AR
Hepatogastroenterology; 2002; 49(45):798-802. PubMed ID: 12063993
[TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic hepatitis B: Evolution over two decades.
Yuen MF; Lai CL
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():138-43. PubMed ID: 21199525
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic viruses and hepatocellular carcinoma.
Ben Ari Z; Weitzman E; Safran M
Clin Liver Dis; 2015 May; 19(2):341-60. PubMed ID: 25921667
[TBL] [Abstract][Full Text] [Related]
11. Impact of HBV therapy on the incidence of hepatocellular carcinoma.
Triolo M; Della Corte C; Colombo M
Liver Int; 2014 Feb; 34 Suppl 1():139-45. PubMed ID: 24373091
[TBL] [Abstract][Full Text] [Related]
12. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
Lim SG; Mohammed R; Yuen MF; Kao JH
J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
[TBL] [Abstract][Full Text] [Related]
13. Treatment of chronic viral hepatitis.
Main J; McCarron B; Thomas HC
Antivir Chem Chemother; 1998 Nov; 9(6):449-60. PubMed ID: 9865383
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot study.
Lee HW; Lee JI; Um SH; Ahn SH; Chang HY; Park YK; Hong SP; Moon YM; Han KH
J Gastroenterol Hepatol; 2008 May; 23(5):729-35. PubMed ID: 18410608
[TBL] [Abstract][Full Text] [Related]
15. [Monitoring patients with chronic hepatitis during and after therapy].
Colić-Cvrlje V; Mise S
Acta Med Croatica; 2009 Dec; 63(5):377-83. PubMed ID: 20198895
[TBL] [Abstract][Full Text] [Related]
16. Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B.
Liaw YF
J Gastroenterol Hepatol; 2004 Dec; 19 Suppl 6():S73-5. PubMed ID: 15546254
[TBL] [Abstract][Full Text] [Related]
17. Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B.
Liaw YF
J Gastroenterol Hepatol; 2004 Dec; 19(12):S73-5. PubMed ID: 15641208
[TBL] [Abstract][Full Text] [Related]
18. Antiviral therapy of HBV- and HCV-induced liver cirrhosis.
Zavaglia C; Airoldi A; Pinzello G
J Clin Gastroenterol; 2000 Apr; 30(3):234-41. PubMed ID: 10777179
[TBL] [Abstract][Full Text] [Related]
19. Thymalfasin in the treatment of hepatitis B and C.
Ciancio A; Rizzetto M
Ann N Y Acad Sci; 2010 Apr; 1194():141-6. PubMed ID: 20536462
[TBL] [Abstract][Full Text] [Related]
20. Thymosin in the treatment of HBeAg-negative chronic hepatitis B.
Saruc M; Ozden N; Yuceyar H
Med Sci Monit; 2003 Aug; 9(8):RA198-202. PubMed ID: 12942046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
